Davis, DC, BCN and Dr. Greg Davis, DC are co-founders Of Essential Neuropathy in Lee’s Summit. They sit down with us to ...

Under the licensing agreement, Alkem will carry out the clinical development of 'SON-080' in India with support from Sonnet ...

Lyka Labs shares rose as the company announced that it has received the CDSCO approval for manufacturing & marketing of of ...

Advantage Neuropathy specializes in providing leading edge pain therapy and treatment that is an FDA cleared solution.

Alkem Laboratories partners with Sonnet BioTherapeutics to develop and commercialize SON-080, a potential treatment for ...

India is grappling with a substantial burden of diabetes-related complications with diabetic peripheral neuropathy being a ...

The diabetic neuropathy market in India was valued at $120.3 million in 2023 and is projected to grow to $246.7 million by 2030. The global market for DPN treatment is expected to reach ...

Mumbai: Alkem Laboratories Ltd. has entered into a licensing agreement with US-based Sonnet BioTherapeutics Holdings, Inc to ...

Despite recent advances in the treatment of breast cancer, it remains the second leading cause of cancer death in the U.S.

There is hope for neuropathy! At Salt Lake Acupuncture Clinic, they blend traditional acupuncture with the latest ...

Sonnet BioTherapeutics Holdings, Inc. (SONN) announced Wednesday that it has entered into a licensing agreement with Alkem ...

Peripheral neuropathy and hearing loss are both common in older patients and seem to be independently and additively related to premature mortality.